FILTER
FILTERED INTERVIEW RESULTS
Ramón Barúa Costa
CEO, ACLARA RESOURCES
Aclara Resources explains how it intends to produce heavy rare earth elements in Chile
Michael Zahra
FORMER PRESIDENT & CEO, DRONE DELIVERY CANADA
"Remote projects may prefer to isolate and limit the number of external individuals visiting as a precaution to avoid the virus spreading, but they need to maintain their supply chain so drones are a perfect unmanned logistics solution."
Claudio Gorichon
CEO, GRUPO RENO S.A.
"Reno is always looking for new development alternatives and we favor organic growth."
Alberto Laveran
SENIOR VICE PRESIDENT – LATAM REGION, VANTAGE SPECIALTY CHEMICALS
“We chose Bogotá as Vantage’s Latam HQ because of its strategic location to serve the region with connection to every single market. The Bogotá office is doing so well that we are now providing some global operations support to our US offices.”
Cecilia Pardo Pizarro
GENERAL MANAGER, OXIQUIM
"Despite the challenges, in 2020 we achieved the best results in the history of the company. Oxiquim has a profit sharing system, and it was very positive for the workers."
Eugenio Manzano
EXECUTIVE DIRECTOR, POCHTECA
"Covid, climate change and geopolitical disruptions will not disappear soon so we need to continue innovating supply chain solutions, strengthening alliances with core suppliers and customers, developing new suppliers and increasing safety stocks to get us through shortages or logistics problems."
Adriana Nobre
MANAGING DIRECTOR - LATIN AMERICA, CRODA
Croda explains how it intends to continue its growth across Latin America.
Rodrigo Gutierrez
CEO, GTM HOLDINGS
GTM Holdings explains how it is experiencing increasing demand for chemicals across the spectrum in Latin America.
Etienne Lepoutre
PRESIDENT – LATIN AMERICA REGION, AIR LIQUIDE
Air Liquide explains how it is managing rapid demand for both industrial and medical gases in Latam.
Claudio Lesch
PRESIDENT SOUTH AMERICA, AUSENCO
Ausenco updates GBR on its operations in Chile and Peru.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
